StockData
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc. (OVID) stock

OVIDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$2.26+0.04 (+1.80%)

Close on Nov 18, 2026Market cap $441.37MP/E –Yield –

Ovid Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Ovid Therapeutics's price to sales ratio was 324.5× on Nov 11, 2026, against 19.2× a year earlier. Over the last 5 years it ranged from 0.9× to 457.0×, with a median of 64.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026324.5×+306.9
2025Dec 31, 202517.5×−87.4
2024Dec 31, 2024104.9×−63.0
2023Apr 28, 2023167.9×+77.9
2022Dec 30, 202290.0×+89.0
2021Dec 31, 20211.0×–

More Ovid Therapeutics figures

See a number that looks wrong?